Feb 20 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- HY TOTAL REVENUE FROM ORDINARY ACTIVITIES DOWN 33.03% TO A$360.3M
- HY PROFIT ATTRIBUTABLE DOWN 80.48% TO A$25.4M
- DECLARED INTERIM DIVIDEND OF 7.00 AU CENTS PER SHARE
Feb 20 (Reuters) - Australian Clinical Labs Ltd (ACL) : HY...
Add to My Watchlist
What is My Watchlist?